NEW YORK (GenomeWeb) – Pressure Biosciences said today that is has completed the fourth closing of its $5 million private placement.

With the closing the company raised an additional $730,000, bring the total amount raised in the offering to nearly $4.8 million. It will issue senior secured debentures with a fixed conversion price of $.28 per restricted common share and common stock purchase warrants exercisable into a total of 1,303,571 shares of restricted stock at an exercise price of $.40 per share.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.